Ticker Details
Arcellx, Inc. Common Stock
IPO Date:	February 4, 2022
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$3.71B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.20 | 2.67%
Avg Daily Range (30 D):	$1.28 | 1.89%
Avg Daily Range (90 D):	$1.62 | 2.13%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	2.29M
Avg Daily Volume (90 D):	1.28M

Trade Size
Avg Trade Size (Sh.):	57
Avg Trade Size (Sh.) (30 D):	108
Avg Trade Size (Sh.) (90 D):	79

Institutional Trades
Total Institutional Trades:	2,641
Avg Institutional Trade:	$3.28M
Avg Institutional Trade (30 D):	$6.99M
Avg Institutional Trade (90 D):	$5.39M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.55M
Avg Closing Trade (30 D):	$9.39M
Avg Closing Trade (90 D):	$8.07M
Avg Closing Volume:	83.1K

News

Feb 24, 2026 @ 8:51 PM Halper Sadeh LLC is Investigating Whether ACLX, EH... Source: Halper Sadeh Llc

Feb 23, 2026 @ 3:48 PM Arcellx Surges as Gilead’s $7.8B Offer Lock... Source: Timothy Fries

Feb 23, 2026 @ 12:51 PM Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma... Source: Vandana Singh

Oct 8, 2025 @ 5:00 PM CAR T-Cell Therapy for Multiple Myeloma Market to ... Source: Delveinsight

May 23, 2025 @ 1:10 PM New Data and Deal Flow Signal a Turning Point for ... Source: Prnewswire

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.99	$-.94
Diluted EPS		$-.99	$-.94
Revenue		$4.95M	$7.55M
Gross Profit
Net Income / Loss		$-55.78M	$-52.77M
Operating Income / Loss		$-61.78M	$-58.73M
Cost of Revenue
Net Cash Flow		$16.87M	$-18.73M
PE Ratio